Navigation Links
Prime Therapeutics Receives TIPPS Certification
Date:9/6/2007

ST. PAUL, Minn., Sept 6 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today its 2008 Transparency in Pharmaceutical Purchasing Standards SM (TIPPS SM) certification.

TIPPS requirements are set forth by the HR Policy Association Pharmaceutical Coalition, an alliance of major employers formed in 2004. The TIPPS initiative calls for adherence to nine drug purchasing transparency standards, including providing acquisition costs for all drugs through mail service and specialty pharmacy.

Prime's private ownership structure by not-for-profit Blue Cross and Blue Shield Plans allows for extensive disclosure and transparent business practices. "Prime was founded on principles of transparency, disclosure and working in the best interests of our clients," said Matt Yordy, Senior Vice President of Business Development at Prime. "We remain committed to these ideals and to demonstrating them to the marketplace. TIPPS is an extension of this commitment."

Cory Super, Prime's Senior Director of National Account Sales, indicates that in order for transparency to have an optimum impact on consumers, all participants in the pharmacy delivery channel, including plan sponsors and employer groups, must share a commitment to transparency. "The TIPPS initiative eliminates the 'shell game' that may exist in the pharmacy benefit management (PBM) market today. It mandates pass-through of negotiated discounts, drug costs and PBM revenue streams as well as demands adherence to disclosure and audit requirements," says Super. "TIPPS ensures employer groups have a consistent way to really check under the hood."

TIPPS is administered by the Pharmaceutical Coalition. The Coalition includes fifty-eight companies representing more than 5 million lives with collective drug spending in 2005 of more than $4.9 billion. TIPPS certification requires PBMs to pass along 100 percent of all revenue from drug manufacturers related to the employer's contract. It also includes rigorous audit rights to guarantee compliance. TIPPS certification requires an annual renewal process.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 12.5 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by ten Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

Transparency in Pharmaceutical Purchasing Standards and TIPPS are service marks of Health Care Policy Roundtable, LLC.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Aggressiveness is a prime heart disease risk
3. Prime Minister Manmohan Against Incentive-Based Population Control
4. Prime Minister Declares War on AIDS
5. Indian Prime Minister undergoes Minor Surgery in AIIMS
6. Movie Smoking Is The Prime Triggering Factor For Adolescents
7. Plastic Surgery Is Primetime among Ethnic Groups
8. Prime Suspect Apprehended in AIIMS Question Paper Leak
9. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
10. Prime Minister Asks Medicos to End Strike
11. Prime Minister Reassure Medical Students Asks them to Call off Strike
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: